Marc de Garidel - CEO and Interim Chairman @ Abivax

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Person)

185,244

Primary Job Title CEO and Interim Chairman
Primary Organization
Abivax

Location Greater Boston Area, United States, North America
Regions East Coast, New England
Gender Male

Facebook View on Facebook
LinkedIn View on LinkedIn

Marc De Garidel is the CEO and Interim Chairman of Abivax. He previously worked at CinCor Pharma, Inc as a CEO. Marc De Garidel attended Harvard Business School.

Jobs

Number of Current Jobs

Number of Past Jobs

Marc de Garidel

has

current jobs as

CEO and Interim Chairman

Abivax

and

CEO

CinCor Pharma

. Additionally,

Marc de Garidel

has had

past jobs including

CEO

AZTherapies

Abivax CEO and Interim ChairmanApr 2023
CinCor Pharma CEOJul 2021

Organization Name	Title At Company	Start Date	End Date
AZTherapies	CEO	Sep 2020	May 2021
Corvidia	Chief Executive Officer	Jan 2018	Aug 2020

Board and Advisor Roles

Number of Current Board & Advisor Roles

Marc de Garidel

is the

Chairman

Ipsen

Ipsen ChairmanJul 2016

Related Hubs

Hub Name	CB Rank (Hub)
Companies that Went Public in 2023	11,818
Therapeutics Companies that Exited	18,715
Claret Capital Partners Portfolio Companies	59,857
TCG Crossover Portfolio Companies	82,741
Health Care Public Companies With Less Than $50M in Revenue	25,430
Therapeutics Companies With More Than 50 Employees	13,887
Therapeutics Public Companies With More Than $1M in Revenue	49,123
Therapeutics Public Companies With Less Than $1B in Revenue	42,337
Therapeutics Public Companies With More Than 10 Employees	39,771
Health Care Public Companies With Fewer Than 100 Employees	29,430

Education

Marc de Garidel

studied at

Harvard Business School

and

Thunderbird School of Global Management

Harvard Business School unknownunknown
Thunderbird School of Global Management unknownunknown